Celastrol Synergistically Enhances Temozolomide Cytotoxicity in Melanoma Cells

Molecular Cancer Research - United States
doi 10.1158/1541-7786.mcr-09-0243
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Sulforaphane Synergistically Enhances the Cytotoxicity of Arsenic Trioxide in Multiple Myeloma Cells via Stress-Mediated Pathways

Oncology Reports
MedicineCancer ResearchOncology
2012English

Inhibiting the mTOR Pathway Synergistically Enhances Cytotoxicity in Ovarian Cancer Cells Induced by Etoposide Through Upregulation of C-Jun

Clinical Cancer Research
Cancer ResearchOncology
2011English

The Role of Autophagy Inhibition in the Enhanced Cytotoxicity of Temozolomide on Melanoma Cell Lines

Advances in molecular oncology
2017English

Temozolomide Induces Senescence but Not Apoptosis in Human Melanoma Cells

British Journal of Cancer
Cancer ResearchOncology
2007English

Optimizing a Novel Regional Chemotherapeutic Agent Against Melanoma: Hyperthermia-Induced Enhancement of Temozolomide Cytotoxicity

Clinical Cancer Research
Cancer ResearchOncology
2006English

Connexin 43 Enhances the Cisplatin-Induced Cytotoxicity in Mesothelioma Cells

2012English

Preclinical Studies of Celastrol and Acetyl Isogambogic Acid in Melanoma

Clinical Cancer Research
Cancer ResearchOncology
2007English

Guanosine Promotes Cytotoxicity via Adenosine Receptors and Induces Apoptosis in Temozolomide-Treated A172 Glioma Cells

Purinergic Signalling
Molecular NeuroscienceCell BiologyMolecular BiologyCellular
2017English

Α-Mangostin Enhances Betulinic Acid Cytotoxicity and Inhibits Cisplatin Cytotoxicity on HCT 116 Colorectal Carcinoma Cells

Molecules
Organic ChemistryMolecular MedicineAnalytical ChemistryTheoretical ChemistryPharmaceutical ScienceMedicineDrug DiscoveryChemistryPhysical
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy